This Is the $8 Trillion Opportunity VCs and Founders Can't Ignore

"According to a UBS report from March 2025, the longevity market is expected to grow from $5.3 trillion in 2023 to $8 trillion by 2030, surpassing even AI, which is projected to reach $1.16 trillion by 2027. Within this broader longevity economy, the most compelling gap lies in healthspan, the years we live in good health, free from chronic disease."

"World Health Organization data from 2024 shows a roughly decade-long gap between average global lifespan at 71.4 years and healthspan at 61.9 years. Scientific American echoed this in 2025, noting that while lifespans have improved, healthspans have largely remained flat. Closing that almost decade-long gap is both a public heal[th opportunity]."

"As populations age across the U.S., Europe and Asia, demand is shifting from simply extending life to extending quality of life. By 2050, more than 2 billion people globally will be over the age of 60, and in the U.S., adults over 65 are set to make up nearly a quarter of the population within the next decade."

The longevity market is experiencing rapid acceleration, projected to grow from $5.3 trillion in 2023 to $8 trillion by 2030, outpacing AI market expansion. The critical opportunity lies in healthspan—the quality years of life free from chronic disease—rather than merely extending lifespan. Global populations are aging significantly, with over 2 billion people expected to exceed age 60 by 2050. Current data reveals a concerning decade-long gap between average global lifespan at 71.4 years and healthspan at 61.9 years. While lifespans have improved, healthspans have remained relatively flat. This gap presents substantial opportunities for entrepreneurs and investors developing preventative health solutions and evidence-based interventions that enhance quality of life.

Read at Entrepreneur